China Phase II Clinical Study of Osemitamab Completes Enrollment for First-Line Gastric Cancer Treatment

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

May 03, 2023 | Wednesday | News
EirGenix's EG1206A Meets Phase 1 Trial Objectives as Breast Cancer Biosimilar

EG1206A is a biosimilar drug of the second-generation HER2-positive antibody drug Perjeta® (pertuzumab). EG1206A has a unique binding mechanism for HER...

May 03, 2023 | Wednesday | News
Eppendorf and Clustermarket Partner for Seamless Integration of Lab Management Tools

With research and development being a time-consuming industry, there is a constant need for time-saving digital solutions and tools. Nowadays, most laborat...

May 03, 2023 | Wednesday | News
Ascletis' Once-Daily Oral FASN Inhibitor, ASC40, Meets Phase II Endpoint for Acne

ASC40 is an oral, selective small molecule inhibitor of FASN. Mechanisms of ASC40 for acne are (1) direct inhibition of facial sebum production, through in...

May 03, 2023 | Wednesday | News
Merck to Establish BioProcessing Production Center in South Korea

MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daejeon City...

May 03, 2023 | Wednesday | News
PharmAla Biotech to form Australian Psychedelics Joint Venture with Vitura Health

PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce the establishment of a 50:50 joint venture, "Cortexa", with Austr...

May 02, 2023 | Tuesday | News
The Clinician to participate at Digital Health Festival 2023 in Melbourne

As a sponsor of the event, The Clinician team will be showcasing their healthcare solutions on the exhibition floor at booth F18 and will be hosting a dedi...

May 01, 2023 | Monday | News
Abbott Completes Acquisition of Cardiovascular Systems, Inc.

The transaction provides Abbott with a complementary solution for treating vascular disease. CSI's leading atherectomy system prepares vessels for angiopla...

April 28, 2023 | Friday | News
Corning's New Advanced Flow Pharmaceutical Technology Services Will Help Speed the Creation of Future Medicines

Corning Incorporated  announced the launch of its Advanced Flow Pharmaceutical Technology (AFPT) services business to help contract development m...

April 27, 2023 | Thursday | News
MGI and South Australian Genomics Centre Introduce DNBSEQ-T7* to Supercharge Genomics Research in Australia

Located in the prestigious SAHMRI building in Adelaide, SAGC is a nationally accredited genomics facility that supports research nationally and internation...

April 27, 2023 | Thursday | News
BioCina awarded Grants to develop enabling technologies for manufacture of precision mRNA vaccines

The grant has been awarded by the Australian Government's National Health and Medical Research Council (NHMRC), and will be matched by the South Australian...

April 27, 2023 | Thursday | News
Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid

Dedicaid's core asset is a clinical decision support software (CDSS) AI platform capable of rapidly generating indication-specific CDSS applications from a...

April 27, 2023 | Thursday | News
AmerisourceBergen Launches Cell and Gene Therapy Integration Hub

-AmerisourceBergen, a global healthcare company, today announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integr...

April 26, 2023 | Wednesday | News
AGC Biologics Received Bioprocessing Excellence Award in Japan

The Asia-Pacific Bioprocessing Excellence Awards (ABEA), hosted by IMAPAC, gives recognition to exceptional Asian bioprocessing companies for their achieve...

April 26, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close